These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [New approach to pathogenesis of genetic hyperlipoproteinemias]. Koizumi J; Inazu A; Mabuchi H Rinsho Byori; 1993 May; 41(5):519-26. PubMed ID: 8350515 [TBL] [Abstract][Full Text] [Related]
10. [Hyperlipoproteinemia mass screening in a pediatric patient group]. László A; Joó I; Turi S Kinderarztl Prax; 1982 Oct; 50(10):506-17. PubMed ID: 7154521 [No Abstract] [Full Text] [Related]
11. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia]. Steinmetz A; Schäfer JR Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933 [TBL] [Abstract][Full Text] [Related]
14. [Classification of hyperlipoproteinemias and interpretation of laboratory parameters]. Herrmann W; Lackner KJ; Schmitz G Wien Med Wochenschr; 1994; 144(12-13):292-9. PubMed ID: 8650932 [TBL] [Abstract][Full Text] [Related]
15. [Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension]. Pogozheva AV; Samsonov MA; Levachev MM Vopr Pitan; 1996; (1):34-6. PubMed ID: 9157710 [TBL] [Abstract][Full Text] [Related]
17. The "game of life": getting to know the players and their tactics. Ordovas JM Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):313-5. PubMed ID: 12669677 [No Abstract] [Full Text] [Related]
18. [Familial and genetic factors in lipoproteinemia disorders]. Sova J Cas Lek Cesk; 1984 Jun; 123(25):753-7. PubMed ID: 6467322 [No Abstract] [Full Text] [Related]